This post was originally published on this site
The first appointment will be before Humana (NYSE:HUM)’s 2022 annual shareholder meet and the second one will follow that, the health insurer said.
“We believe Humana is well positioned to continue delivering Medicare Advantage market share gains, improved profitability, and earnings growth as it executes on its strategies, captures the significant opportunities ahead and enhances value for shareholders,” said Jeff Smith, Starboard’s chief executive officer.
